Thank you, Madam Chair. I certainly look forward to the results of that. I think there is also a bit of a national conversation going on with pharmacare, and I think the department is also looking at what is driving health costs everywhere. That's obviously a national conversation. In that regard, I see both medical travel and Extended Health Benefits have quite significant increases from the revised estimates. I will start with: can we get a sense of what is driving the cost in Extended Health Benefits? Thank you, Madam Chair.